Menu
Annual · values202520242023202220212020201920182017201620152014
Operating Cash Flow-3.84 M USD-5.36 M USD-5.47 M USD-480532 USD-5.25 M USD-4.30 M USD-2.24 M USD-1.17 M USD-722858 USD-208782 USD-405481 USD-862273 USD
Depreciation & Amortization87000 USD81000 USD84000 USD100000 USD104715 USD105299 USD101216 USD111055 USD144887 USD156283 USD178219 USD177518 USD
Stock-Based Compensation460000 USD837000 USD1.19 M USD1.26 M USD
Capital Expenditures51000 USD64000 USD56900 USD135856 USD33608 USD101137 USD130347 USD96085 USD91556 USD10503 USD137234 USD
Cash Flow from Investing-37000 USD-115000 USD-78000 USD-170336 USD-295583 USD-118927 USD-171111 USD-130347 USD-96085 USD-95192 USD-22782 USD-282530 USD
Cash Flow from Financing2.11 M USD-81000 USD9.39 M USD2.39 M USD1.11 M USD12.37 M USD1.91 M USD1.29 M USD157728 USD1.11 M USD9560 USD185275 USD
Dividends Paid
Stock Buybacks
Free Cash Flow-5.41 M USD-5.54 M USD-537432 USD-5.39 M USD-4.33 M USD-2.35 M USD-1.30 M USD-818943 USD-300338 USD-415984 USD-999507 USD

Biomerica Inc. operates within the healthcare sector as a developer and manufacturer of advanced medical diagnostic products. The primary function of Biomerica Inc. is to innovate in the realm of diagnostic testing, with a focus on chronic diseases and conditions. Their portfolio includes products designed for the early detection and management of illnesses such as diabetes, gastrointestinal disorders, and various forms of cancer. Through its cutting-edge technology, Biomerica Inc. aims to improve patient care by offering precise and reliable testing solutions that can be utilized in clinical laboratories, hospitals, and research institutions. Biomerica's work significantly impacts the healthcare industry by catering to the rising demand for efficient diagnostic tools that help in timely disease intervention. Based in Irvine, California, and with a global presence, Biomerica Inc. positions itself as a pivotal player in enhancing healthcare delivery and contributing to clinical advancements by providing products that drive better health outcomes.